VIR
Vir Biotechnology, Inc. · Healthcare
President and CEO George A Scangos sold $863K of Vir Biotechnology, Inc.
Sold$863,378
$31.11Price
27,750Shares
What VIR did after the filing
- The stock from Tue, Feb 22 close, $29.48
- −23.9%
- S&P 500, same days
- +5.3%
Measured over 30 trading days, to the Apr 5 close.
Traded Thu, Feb 17. Filed Tue, Feb 22, 12:01 PM ET, during the session. Returns use the Feb 22 close and the Apr 5 close. Not investment advice.